Neurocrine Biosciences | 净收入

Net Income 更改 日
AbbVie USD 1.37B 547M 2024-03
Acadia Pharmaceuticals USD 16.56M 29.24M 2024-03
Agios Pharmaceuticals USD -81549000 14.39M 2024-03
ALKERMES USD 36.83M 75.95M 2024-03
Alnylam Pharmaceuticals USD -65935000 71.94M 2024-03
Amgen USD -113000000 880M 2024-03
Biogen USD 393.4M 143.7M 2024-03
BioMarin Pharmaceutical USD 88.66M 68.29M 2024-03
Cytokinetics USD -135643000 1.25M 2024-03
Dynavax Technologies USD -8721000 8.94M 2024-03
Exelixis USD 37.32M 36.28M 2024-03
Gilead Sciences USD -4170000000 5.6B 2024-03
Halozyme Therapeutics USD 76.82M 8.56M 2024-03
Incyte USD 169.55M 31.53M 2024-03
Intra Cellular Therapies USD -15247000 13.33M 2024-03
Ionis Pharmaceuticals USD -142803000 133.54M 2024-03
Neurocrine Biosciences USD 43.4M 39.7M 2024-03
Pfizer USD 3.12B 6.48B 2024-03
Prothena USD -72239000 4.76M 2024-03
Regeneron Pharmaceuticals USD 722M 437.6M 2024-03
Repligen USD 2.09M 27.58M 2024-03
Sarepta Therapeutics USD 36.12M 77.06M 2024-03
Teva Pharmaceutical Industries USD -139000000 600M 2024-03
Ultragenyx Pharmaceutical USD -170684000 47.49M 2024-03
Vertex Pharmaceuticals USD 1.1B 64.3M 2024-03



Neurocrine Biosciences 净收入 - 当前值，历史数据，预测，统计，图表和经济日历 - Jun 2024.